Ewayan, Jecel .
HRN: 26-16-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2024
CEFUROXIME 750MG (VIAL)
11/07/2024
11/13/2024
IVT
1.5g
Q8hrs
Post Op Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes